1. Sun, Jian, Wang, Fei, Zhou, Huihui, Fan, Caibin, Wang, Jianqing. 2022. Downregulation of PGM5 expression correlates with tumor progression and poor prognosis in human prostate cancer. In Discover oncology, 13, 63. doi:10.1007/s12672-022-00525-x. https://pubmed.ncbi.nlm.nih.gov/35819729/
2. Du, Lei, Gao, Yongli. 2021. PGM5-AS1 impairs miR-587-mediated GDF10 inhibition and abrogates progression of prostate cancer. In Journal of translational medicine, 19, 12. doi:10.1186/s12967-020-02572-w. https://pubmed.ncbi.nlm.nih.gov/33407592/
3. Hui, Bingqing, Lu, Chen, Wang, Jing, Wang, Keming, Gu, Yanhong. 2021. Engineered exosomes for co-delivery of PGM5-AS1 and oxaliplatin to reverse drug resistance in colon cancer. In Journal of cellular physiology, 237, 911-933. doi:10.1002/jcp.30566. https://pubmed.ncbi.nlm.nih.gov/34463962/
4. Wang, Jiajun, Ye, Jun, Dang, Yuxue, Xu, Shun. 2024. LncRNA PGM5-AS1 inhibits non-small cell lung cancer progression by targeting miRNA-423-5p/SLIT2 axis. In Cancer cell international, 24, 216. doi:10.1186/s12935-024-03402-5. https://pubmed.ncbi.nlm.nih.gov/38902704/
5. Zhou, B, Yi, F, Chen, Y, Cheng, Y-S, Yang, K. . Reduced long noncoding RNA PGM5-AS1 facilitated proliferation and invasion of colorectal cancer through sponging miR-100-5p. In European review for medical and pharmacological sciences, 24, 7972-7981. doi:10.26355/eurrev_202008_22480. https://pubmed.ncbi.nlm.nih.gov/32767323/
智鼠故事 
